Get your highest score possible on the MPJE® with detailed state-specific guidance! Complete coverage of 20 states, plus federal regulations! Pharmacy Law is the perfect way to prepare for the MPJE Exam. It delivers a rigorous review of pharmacy-related statutes, rules, and regulations that impact pharmacy practice in twenty states as well as a summary of federal regulations that pertain to pharmacy law. Federal coverage includes summaries of must-know legislation such as the Federal Controlled Substances Act, the Federal Food, Drug & Cosmetics Act, and other relevant federal guidelines. State-specific chapters discuss important topics such as renewal of pharmacists’ licenses, qualifications, prescription transfers, inventory requirements, record-keeping, and prescriptive authority. Each chapter concludes with practice scenarios and questions with appropriate explanations. The Review You Need to Excel in These States: Alabama, Arizona, Arkansas, California, Colorado, Florida, Georgia, Illinois, Indiana, Kentucky, Louisiana, Maryland, North Carolina, New Jersey, Ohio, Oregon, Pennsylvania, South Carolina, Texas & Wisconsin. Watch for future supplements with additional states.

Order from rxpharmacist.com for the cheapest deal! You asked. We delivered. This review guide was thoughtfully created by recent pharmacy graduates for recent, soon to be pharmacy graduates or even the seasoned pharmacist wanting to get licensed in the state of IL. Based off previous customer feedback, we spent months created this guide with no detail left unchecked. It is meant to be an extensive yet simple guide to pass your board exams easily. This study guide will save you from weeks of frustration and help focus on key points to study for the IL MPJE exam. One of the most updated guides out there, we also include a mock 120-question IL state practice exam that highly mimics the actual IL MPJE so you can test your knowledge. In addition, we also include a 120-question federal practice exam. That's over 240 practice questions! Want more guides or need more help? Visit us at www.rxpharmacist.com.

Order from rxpharmacist.com for the cheapest deal! Updated for the 2019-2020 year! You asked. We delivered. This review guide was thoughtfully created by recent pharmacy graduates for recent, soon to be pharmacy graduates or even the seasoned pharmacist wanting to get licensed in the state of IL. Based off previous customer feedback, we spent months created this guide with no detail left unchecked. It is meant to be an extensive yet simple guide to pass your board exams easily. This study guide will save you from weeks of frustration and help focus on key points to study for the IL MPJE exam. One of the most updated guides out there, we also include a mock 126-question IL state practice exam that highly mimics the actual IL MPJE so you can test your knowledge. In addition, we also include a 120-question federal practice exam. We also include a BONUS 30 questions. That's over 270 practice questions! Want more guides or need more help? Visit us at www.rxpharmacist.com.

THE ESSENTIAL WORK IN TRAVEL MEDICINE -- NOW COMPLETELY UPDATED FOR 2018 As unprecedented numbers of travelers cross international borders each day, the need for up-to-date, practical information about the health challenges posed by travel has never been greater. For both international travelers and the health professionals who care for them, the CDC Yellow Book 2018: Health Information for International Travel is the definitive guide to staying safe and healthy anywhere in the world. The fully revised and updated 2018 edition codifies the U.S. government's most current health guidelines and information for international travelers, including pretravel vaccine recommendations, destination-specific health advice, and easy-to-reference maps, tables, and charts. The 2018 Yellow Book also addresses the needs of specific types of travelers, with dedicated sections on: · Precautions for pregnant travelers, immunocompromised travelers, and travelers with disabilities · Special considerations for newly arrived adoptees, immigrants, and refugees · Practical tips for last-minute or resource-limited travelers · Advice for air crews, humanitarian workers, missionaries, and others who provide care and support overseas Authored by a team of the world's most esteemed travel medicine experts, the Yellow Book is an essential resource for travelers -- and the clinicians overseeing their care -- at home and abroad.

Covers Updated PTCB Competency Statements!1. Approximately 500 questions with answers and complete explanations. 2. Approximately 1500 drugs with their brand names, generic names, therapeutic uses and adverse effects in easy to read tables.3. Complete exercises on commonly asked pharmaceutical calculations in examination.Includes practice tests.4. Lists of commonly used abbreviations.5. List of drugs requires refrigeration and much more...

Uses real examples of crimes and investigations and then explains how the law pertains to the case.

Drug overdose, driven largely by overdose related to the use of opioids, is now the leading cause of unintentional injury death in the United States. The ongoing opioid crisis lies at the intersection of two public health challenges: reducing the burden of suffering from pain and containing the rising toll of the harms that can arise from the use of opioid medications. Chronic pain and opioid use disorder both represent complex human conditions affecting millions of Americans and causing untold disability and loss of function. In the context of the growing opioid problem, the U.S. Food and Drug Administration (FDA) launched an Opioids Action Plan in early 2016. As part of this plan, the FDA asked the National Academies of Sciences, Engineering, and Medicine to convene a committee to update the state of the science on pain research, care, and education and to identify actions the FDA and others can take to respond to the opioid epidemic, with a particular focus on informing FDA's development of a formal method for incorporating individual and societal considerations into its risk-benefit framework for opioid approval and monitoring.